YourLawyer.com 1-800-LAW-INFO (1-800-529-4636)
Rhabdomyolysis
Rhabdomyolysis
Rhabdomyolysis is a serious disorder that causes kidney damage resulting from toxic effects of the contents of muscle cells. Myoglobin is an iron-containing pigment found in the skeletal muscle. When the skeletal muscle is damaged, the myoglobin is released into the bloodstream. It is filtered out of the bloodstream by the kidneys. Myoglobin may obstruct the structures of the kidney, causing damage such as acute tubular necrosis or kidney failure.Myoglobin breaks down into potentially toxic compounds, which will also cause kidney failure. It is important to treat Rhabdomyolysis quickly. Early and aggressive hydration may prevent complications by rapidly eliminating the myoglobin out of the kidneys. The hydration needs with muscle necrosis may approximate the massive fluid volume needs of a severely burned patient. This may involve intravenous administration of several liters of fluid until the condition stabilizes.
Diuretic medications such as mannitol or furosemide may aid in flushing the pigment out of the kidneys. If the urine output is sufficient, bicarbonate may be given to maintain an alkaline urine state. This helps to prevent the dissociation of myoglobin into toxic compounds.
Rhabdomyolysis results from any condition that causes significant muscle damage. These include:
- Certain muscle diseases
- Severe muscle injuries (e.g., crush injury)
- Overuse of alcohol or illicit drugs
- Use of some prescription drugs
- Severe seizures or convulsions
If you or a loved one has taken the Statin drugs, Baycol or Crestor and have been diagnosed with Rhabdomyolysis, please fill out the form at the right for a free case evaluation by a qualified defective drug attorney.
RhabdomyolysisRSS Feed
Simvastatin and Amiodarone Linked to Possibly Fatal Muscle Disease
Aug 8, 2008 | Parker Waichman Alonso LLP
The combination of simvastatin and amiodarone, an anti-arrhythmia medication, has been linked to a rare muscle condition that can cause kidney damage and death. The Food & Drug Administration (FDA) first warned against combining the drugs in 2002 because of their association with the condition - called rhabdomyolysis - but has continued to received reports of its occurrence.Amiodarone is an ingredient in Wyeth's Cordarone and is also sold generically. Simvastatin is an...
Report: Bayer Held Back on Drug Dangers
Nov 23, 2004 | Los Angeles Times
Another pharmaceutical company may have concealed safety information about a dangerous drug this time Bayer and its once-popular cholesterol medication Baycol according to a report in a prominent medical journal.Baycol was pulled from the market in 2001, but an analysis released Monday by the Journal of the American Medical Assn. argued there were strong indications of its dangers three months after its introduction in 1998.The report adds to concerns that the Food and Drug Administration's...
Advocate Suggests Crestor May Harm Kidneys
Oct 29, 2004 | AP
Consumer advocate Dr. Sidney Wolfe renewed his effort Friday to get the anti-cholesterol drug Crestor removed from sale. Wolfe sent a letter to the Food and Drug Administration citing 29 cases of kidney problems 18 of kidney failure and 11 of kidney insufficiency out of some 4.5 million prescriptions for the drug between Jan. 1, 2001 and Sept. 30, 2003. That is more kidney problems than reported by all other statin-type anti-cholesterol drugs, Wolfe said. Emily Denney, a spokesperson for...
Rate of Kidney Damage in Crestor Patients Is 75 Times Higher Than in Patients Taking Other Cholesterol Drugs
Oct 29, 2004 | www.PharmaLive.com
The rate of reports of kidney failure or damage among patients taking the cholesterol drug Crestor is 75 times higher than in all patients taking all other statins, according to a Public Citizen analysis of government data. Public Citizen sent the information today to the U.S. Food and Drug Administration and renewed its call for the drug to be taken off the market.It becomes clearer by the day that this drug is uniquely toxic but offers no unique benefit, and must be removed from the market,...
Dear Dr. Crawford
Oct 29, 2004 | www.citizen.org
Lester Crawford, DVM, Acting CommissionerFood and Drug Administration5600 Fishers LaneRockville, MD 20854Dear Dr. Crawford,We have just completed an analysis of the FDAs adverse drug reaction database (AERS) and have found that the rate of reports to the FDA of acute renal failure or renal insufficiency per million prescriptions in patients using rosuvastatin (Crestor)29 U.S. reports in less than one year since the drug was first marketed in this country is approximately 75 times higher than...
Rhabdomyolysis
Quick Facts
Rhabdomyolysis Reference Guide
Symptoms
Kidney damage
Muscle damage
Acute tubular necrosis
Kidney failure
Possible Causes
Overuse of alcohol
Illicit drugs overuse
Seizures
Convulsions
Prescription medicines
Statin Drugs
Drugs
Baycol
Crestor
Related Topics
Baycol
Crestor
Kidney Failure
Defective Drugs
Diseases
Kidney damage
Muscle damage
Acute tubular necrosis
Kidney failure
Possible Causes
Overuse of alcohol
Illicit drugs overuse
Seizures
Convulsions
Prescription medicines
Statin Drugs
Drugs
Baycol
Crestor
Related Topics
Baycol
Crestor
Kidney Failure
Defective Drugs
Diseases
News Feeds
WE ALSO OFFER OUR FIRM NEWS AS RSS/XML FEEDS.
LEARN MORE ABOUT RSS
